Plus, it doesnt have all the costs for the design of injection pens, the large manufacturing facility, and distribution
Ongoing studies Our search has detected five ongoing trials that aim to assess the effects of GLP-1 receptor agonists in individuals with PD
However, post hoc and pooled analyses of clinical studies investigating semaglutide in both obesity and T2D have shown that GI AEssuch as nausea, vomiting, and diarrhoeacontribute minimally to overall weight reduction
The question of what to stack with retatrutide for optimal body composition results is one of the most common in the community, and one with the least clinical data to guide decisions
Another phase II study assessed the safety and efficacy of varying doses of retatrutide, included participants with a BMI of 25 to 50 kg/m 2 and an HbA1c of 7.0% to 10.5% [114]